A Schattenberg

6.9k total citations · 1 hit paper
77 papers, 4.0k citations indexed

About

A Schattenberg is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, A Schattenberg has authored 77 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Hematology, 32 papers in Immunology and 14 papers in Genetics. Recurrent topics in A Schattenberg's work include Hematopoietic Stem Cell Transplantation (45 papers), Immune Cell Function and Interaction (16 papers) and Chronic Myeloid Leukemia Treatments (15 papers). A Schattenberg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (45 papers), Immune Cell Function and Interaction (16 papers) and Chronic Myeloid Leukemia Treatments (15 papers). A Schattenberg collaborates with scholars based in Netherlands, France and Germany. A Schattenberg's co-authors include Leo F. Verdonck, Per Ljungman, William Arcese, JM Goldman, Augustin Ferrant, Dietger Niederwieser, HJ Kolb, Bernd Hertenstein, N Jacobsen and T. de Witte and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

A Schattenberg

74 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

1995 1.5k citations A Schattenberg, Augustin Ferrant et al. Blood profile →

Peers

Countries citing papers authored by A Schattenberg

Since Specialization

Citations

This map shows the geographic impact of A Schattenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A Schattenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A Schattenberg more than expected).

Fields of papers citing papers by A Schattenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A Schattenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A Schattenberg. The network helps show where A Schattenberg may publish in the future.

Co-authorship network of co-authors of A Schattenberg

This figure shows the co-authorship network connecting the top 25 collaborators of A Schattenberg. A scholar is included among the top collaborators of A Schattenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A Schattenberg. A Schattenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	High-dose imatinib versus high-dose imatinib in combination with intermediate-dose cytarabine in patients with first chronic phase myeloid leukemia: a randomized phase III trial of the Dutch-Belgian HOVON study group 2013 ·Annals of Hematology ·Noortje Thielen, Bronno van der Holt, Gregor Verhoef, (unknown), Pieter Sonneveld, Jeroen J. W. M. Janssen, Wendy Deenik, J.H. Frederik Falkenburg, Marie José Kersten, Harm Sinnige, Martin R. Schipperus, A Schattenberg, (unknown), Willem M. Smit, (unknown), Peter J.M. Valk, Gert J. Ossenkoppele, Jan J. Cornelissen	6
2	Autologous stem-cell transplantation in patients with mantle cell lymphoma beyond 65 years of age: a study from the European Group for Blood and Marrow Transplantation (EBMT) 2011 ·Annals of Oncology ·Esa Jantunen, (unknown), Michel Attal, Kirsty Thomson, Nöel Milpied, Agnès Buzyn, A Ferrant, Pierre Biron, Charles Crawley, A Schattenberg, J.J. Luan, Hervé Tilly, Bernard Rio, P. Wijermans, Peter Dreger, Anna Sureda	35
3	Is There Still a Place for Total Body Irradiation (TBI) In the Conditioning Regimen of Autologous Stem Cell Transplantation In Mantle Cell Lymphoma ?: a Retrospective Study From the Lymphoma Working Party of the EBMT 2010 ·Blood ·Marie Thérèse Rubio, Ariane Boumendil, (unknown), Carmen Canals, François Lefrère, Michel Attal, Augustin Ferrant, Agnès Buzyn, Bernard Rio, A Schattenberg, (unknown), Hervé Tilly, Pierre Biron, Nöel Milpied, Didier Blaise, Jean‐Pierre Jouet, Charles Crawley, Peter Dreger, Anna Sureda, Olivier Hermine	16
4	Matched unrelated donor stem cell transplant in 131 patients with follicular lymphoma: an analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation 2009 ·British Journal of Haematology ·Irit Avivi, Silvia Montoto, Carme Saurina, J Maertens, Haifa Kathrin Al‐Ali, Ghulam J. Mufti, Jürgen Finke, A Schattenberg, Renato Fanin, Jan J. Cornelissen, Jean‐Paul Vernant, (unknown), Yves Béguin, Kirsty Thomson, Leo F. Verdonck, Guido Kobbe, Hervé Tilly, Gérard Socié, Anna Sureda, (unknown)	30
5	Results of Hematopoietic Stem Cell Transplantation After Treatment With Different High-Dose Total-Body Irradiation Regimens in Five Dutch Centers 2008 ·International Journal of Radiation OncologyBiologyPhysics ·M. Loes van Kempen-Harteveld, Ronald Brand, Henk B. Kal, Leo F. Verdonck, Pieter Hofman, A Schattenberg, (unknown), Jan J. Cornelissen, W M H Eijkenboom, (unknown), Foppe Oldenburger, Renée M. Y. Barge, Anja van Biezen, Jaak M. Vossen, Evert M. Noordijk, H. Struikmans	10
6	Long-term follow-up results after autologous haematopoietic stem cell transplantation for severe systemic sclerosis 2007 ·Annals of the Rheumatic Diseases ·Madelon C Vonk, Zora Marjanovic, F.H.J. van den Hoogen, Sarah Zohar, A Schattenberg, WE Fibbe, (unknown), Éliane Gluckman, Frank Preijers, Arie P.J. van Dijk, J. J. Bax, P. Roblot, P. L. C. M. van Riel, Jacob M. van Laar, Dominique Farge	122
7	Experience of severe fatigue in long-term survivors of stem cell transplantation 2007 ·Bone Marrow Transplantation ·Marieke Gielissen, A Schattenberg, Stans Verhagen, (unknown), (unknown), (unknown)	1
8	[Freezing umbilical-cord blood and bone marrow for one's own use: present-day quackery?]. 2006 ·PubMed ·D.D.M. Braat, Christine L. Mummery, A Schattenberg, (unknown)	1
9	Differences between the different conditioning regimens for allogeneic stem cell transplantation 2006 ·Current Opinion in Oncology ·A Schattenberg, (unknown)	10
10	Cellular adoptive immunotherapy after allogeneic stem cell transplantation 2005 ·Current Opinion in Oncology ·A Schattenberg, Harry Dolstra	21
11	Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms 2003 ·Leukemia ·(unknown), Nicolaas Schaap, (unknown), (unknown), Ismael Buño, Harry Dolstra, T. de Witte, A Schattenberg, E. van de Wiel-van Kemenade	72
12	Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms 2003 ·Leukemia ·(unknown), (unknown), (unknown), (unknown), Ismael Buño, Harry Dolstra, T. de Witte, A Schattenberg, E. van de Wiel-van Kemenade	19
13	The impact of intensive antileukaemic treatment strategies on prognosis of myelodysplastic syndrome patients aged less than 61 years according to International Prognostic Scoring System risk groups 2003 ·British Journal of Haematology ·(unknown), Shulamiet Wittebol, W.A.J.G. Lemmens, Lambertus A. Kiemeney, (unknown), Petra Muus, A Schattenberg, T.J.M. de Witte	15
14	Cost analysis of HLA-identical sibling and voluntary unrelated allogeneic bone marrow and peripheral blood stem cell transplantation in adults with acute myelocytic leukaemia or acute lymphoblastic leukaemia 2002 ·Bone Marrow Transplantation ·Michel van Agthoven, (unknown), LF Verdonck, Bob Löwenberg, A Schattenberg, Machteld Oudshoorn, Anton Hagenbeek, (unknown), (unknown), R. Willemze	47
15	Chimerism patterns in subpopulations of PBMCs in stable mixed chimeras after T-cell depleted SCT 2001 ·Bone Marrow Transplantation ·Nicolaas Schaap, A Schattenberg, Manon H. J. Hillegers, (unknown), A. Pennings, T.J.M. de Witte	0
16	Production of anti-CD3 and anti-CD7 ricin A-immunotoxins for a clinical pilot study 2001 ·International Journal of Pharmaceutics ·(unknown), (unknown), H. Bakker, Frank Preijers, A Schattenberg, Dirk J. Ruiter, (unknown), J. P. Koopman, Théo de Witte	8
17	Cytotoxic T-lymphocyte precursor frequency (CTLp-f) as a tool for distinguishing permissible from non-permissible class I mismatches in T-cell-depleted allogeneic bone marrow transplantation 2000 ·British Journal of Haematology ·Arnold van der Meer, Irma Joosten, A Schattenberg, T.J.M. de Witte, Wil A. Allebes	22
18	Red blood cell phenotyping is a sensitive technique for monitoring chronic myeloid leukaemia patients after T‐cell‐depleted bone marrow transplantation and after donor leucocyte infusion 2000 ·British Journal of Haematology ·Nicolaas Schaap, A Schattenberg, Brigitte Bär, E. J. B. M. Mensink, (unknown), Ad Geurts van Kessel, T. de Witte	23
19	Counterflow centrifugation allows addition of appropriate numbers of T cells to allogeneic marrow and blood stem cell grafts to prevent severe GVHD without substantial loss of mature and immature progenitor cells 1999 ·Bone Marrow Transplantation ·(unknown), Paula B. van Hennik, A Schattenberg, (unknown), RE Ploemacher, T de Witte	6
20	Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. 1993 ·Journal of Clinical Oncology ·Brigitte Bär, A Schattenberg, E. J. B. M. Mensink, Ad Geurts van Kessel, Toon F.C.M. Smetsers, (unknown), (unknown), T. de Witte	139

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact